HK1252322A1 - 製備細胞毒性苯並二氮雜䓬衍生物的方法 - Google Patents

製備細胞毒性苯並二氮雜䓬衍生物的方法

Info

Publication number
HK1252322A1
HK1252322A1 HK18111602.7A HK18111602A HK1252322A1 HK 1252322 A1 HK1252322 A1 HK 1252322A1 HK 18111602 A HK18111602 A HK 18111602A HK 1252322 A1 HK1252322 A1 HK 1252322A1
Authority
HK
Hong Kong
Prior art keywords
methods
benzodiazepine derivatives
cytotoxic benzodiazepine
preparing cytotoxic
preparing
Prior art date
Application number
HK18111602.7A
Other languages
English (en)
Inventor
Baudouin Gérard
Manami Shizuka
Michael Louis Miller
Richard A Silva
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of HK1252322A1 publication Critical patent/HK1252322A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK18111602.7A 2015-07-21 2018-09-10 製備細胞毒性苯並二氮雜䓬衍生物的方法 HK1252322A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562195023P 2015-07-21 2015-07-21
US201662327973P 2016-04-26 2016-04-26

Publications (1)

Publication Number Publication Date
HK1252322A1 true HK1252322A1 (zh) 2019-05-24

Family

ID=56557925

Family Applications (3)

Application Number Title Priority Date Filing Date
HK18111603.6A HK1252323A1 (zh) 2015-07-21 2018-09-10 製備細胞毒性苯並二氮雜䓬衍生物的方法
HK18111601.8A HK1252321A1 (zh) 2015-07-21 2018-09-10 製備細胞毒性苯並二氮雜䓬衍生物的方法
HK18111602.7A HK1252322A1 (zh) 2015-07-21 2018-09-10 製備細胞毒性苯並二氮雜䓬衍生物的方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK18111603.6A HK1252323A1 (zh) 2015-07-21 2018-09-10 製備細胞毒性苯並二氮雜䓬衍生物的方法
HK18111601.8A HK1252321A1 (zh) 2015-07-21 2018-09-10 製備細胞毒性苯並二氮雜䓬衍生物的方法

Country Status (22)

Country Link
US (11) US9890179B2 (zh)
EP (7) EP4286387A3 (zh)
JP (8) JP6787995B2 (zh)
KR (5) KR20240055903A (zh)
CN (5) CN108055844A (zh)
AU (7) AU2016297607A1 (zh)
CA (4) CA2992082A1 (zh)
CY (2) CY1122553T1 (zh)
DK (2) DK3325482T3 (zh)
ES (4) ES2764548T3 (zh)
HK (3) HK1252323A1 (zh)
HR (1) HRP20201479T1 (zh)
HU (1) HUE051541T2 (zh)
IL (10) IL305279A (zh)
LT (2) LT3325482T (zh)
PL (2) PL3325483T3 (zh)
PT (2) PT3325482T (zh)
RS (2) RS59806B1 (zh)
RU (3) RU2018105752A (zh)
SG (2) SG10202009354SA (zh)
SI (2) SI3325482T1 (zh)
WO (3) WO2017015496A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3325482T (lt) 2015-07-21 2020-11-25 Immunogen, Inc. Citotoksinių benzodiazepino darinių paruošimo būdai
EP3433875B1 (de) 2016-03-22 2022-05-04 EV Group E. Thallner GmbH Verfahren zum bonden von substraten
KR102617264B1 (ko) 2016-10-19 2023-12-29 인벤라 인코포레이티드 항체 구조물
EA201991204A1 (ru) 2016-12-22 2019-12-30 Университа Дельи Студи Манья Греча Катандзаро Моноклональное антитело против уникального сиалогликозилированного опухолеассоциированного эпитопа cd43
CN116102615A (zh) * 2017-01-25 2023-05-12 伊缪诺金公司 制备细胞毒性苯二氮䓬衍生物的方法
JP2021527047A (ja) 2018-06-05 2021-10-11 キングス・カレッジ・ロンドン 消化管系へのペイロード送達のための、ｂｔｎｌ３／８を標的とする構築物
US10851117B2 (en) 2018-11-12 2020-12-01 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
IL308670A (en) * 2018-11-12 2024-01-01 Immunogen Inc Methods for preparing cytotoxic benzodiazepine derivatives
TW202102506A (zh) * 2019-03-29 2021-01-16 美商伊繆諾金公司 苯二氮平衍生物

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860600A (en) 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
US3763183A (en) 1972-07-10 1973-10-02 Sterling Drug Inc 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines
US4678784A (en) 1984-04-11 1987-07-07 Mcneilab, Inc. Method for the treatment of LHRH diseases and conditions
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
GB9205051D0 (en) 1992-03-09 1992-04-22 Cancer Res Campaign Tech Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them
ES2149768T3 (es) 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
DE69930328T2 (de) 1998-08-27 2006-12-14 Spirogen Ltd., Ryde Dimere Pyrrolobenzodiazepine
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
NZ517772A (en) 1999-11-24 2004-03-26 Immunogen Inc Cytotoxic agents comprising taxanes and their therapeutic use
US6548042B2 (en) * 2000-08-07 2003-04-15 Arstad Erik Bis-phosphonate compounds
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6756397B2 (en) 2002-04-05 2004-06-29 Immunogen, Inc. Prodrugs of CC-1065 analogs
CA2494074A1 (en) 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
DE60336149D1 (de) 2002-08-16 2011-04-07 Immunogen Inc Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
RU2338747C2 (ru) 2003-03-31 2008-11-20 Каунсил Оф Сайентифик Энд Индастриал Рисерч ДИМЕРЫ ПИРРОЛО [2, 1-c][1, 4] БЕНЗОДИАЗЕПИНА В КАЧЕСТВЕ ПРОТИВООПУХОЛЕВЫХ СРЕДСТВ И СПОСОБ ИХ ПОЛУЧЕНИЯ
CA2520897C (en) 2003-03-31 2010-08-24 Council Of Scientific And Industrial Research Pyrrolo (2,1-c)(1,4) benzodiazepine dimers as antitumour agents and process thereof
AU2003215821B2 (en) 2003-03-31 2009-04-23 Council Of Scientific And Industrial Research Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof
RU2314309C2 (ru) 2003-03-31 2008-01-10 Каунсил Оф Сайентифик Энд Индастриал Рисерч Пирроло [2.1-c][1.4] бензодиазепины, способ их получения и фармацевтическая композиция на их основе
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
CA2543318C (en) 2003-10-22 2013-01-08 B. Rao Vishnuvajjala Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
WO2005063759A1 (en) 2003-12-31 2005-07-14 Council Of Scientific And Industrial Research PROCESS FOR PREPARING PYRROLO[2, 1-c] [1, 4] BENZODIAZEPINE HYBRIDS
CA2558195C (en) * 2004-03-01 2012-11-06 Spirogen Limited 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
GB0404578D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
GB0410725D0 (en) 2004-05-13 2004-06-16 Spirogen Ltd Pyrrolobenzodiazepine therapeutic agents
GB0412492D0 (en) * 2004-06-04 2004-07-07 Sterix Ltd Compound
GB0508084D0 (en) * 2005-04-21 2005-06-01 Spirogen Ltd Pyrrolobenzodiazepines
DE602006011300D1 (de) 2005-04-21 2010-02-04 Spirogen Ltd Pyrrolobenzodiazepine
ATE427949T1 (de) 2005-10-05 2009-04-15 Spirogen Ltd 4-a4-(5-oxo-2,3,5,11a-tetrahydro-5h-pyrrolo a2, 1-cua1,4ubenzodiazepin-8-yloxy)-butyrylaminou-1 - pyrrol-2-carbonsaurealkylesterderivate und verwandte verbindung zur behandlung einer proliferativen erkrankung
RU2467007C2 (ru) * 2005-12-21 2012-11-20 Эбботт Лэборетриз Производные [1,8]нафтиридина, полезные в качестве ингибиторов репликации вируса hcv
EP1813614B1 (en) 2006-01-25 2011-10-05 Sanofi Cytotoxic agents comprising new tomaymycin derivatives
WO2007093873A1 (en) 2006-02-13 2007-08-23 Council Of Scientific And Industrial Research Bis-pyrr0l0[2,l-c] [1, 4] benzodiazepine- anthraquinone conjugates as antitumour agents and a process for the preparation thereof
CN103030696B (zh) 2006-05-30 2016-09-28 健泰科生物技术公司 抗体和免疫偶联物及其用途
PL2019104T3 (pl) 2007-07-19 2014-03-31 Sanofi Sa Środki cytotoksyczne obejmujące nowe pochodne tomaymycyny i ich zastosowanie terapeutyczne
EP2188297B1 (en) 2007-08-01 2012-02-01 Council of Scientific & Industrial Research Pyrrolo [2,1-c][1, 4] benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent
KR20210100223A (ko) 2008-04-30 2021-08-13 이뮤노젠 아이엔씨 가교제 및 그 용도
BRPI0911442A2 (pt) 2008-04-30 2019-03-12 Immunogen, Inc. conjugados potentes e ligantes hidrofílicos
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
GB0822260D0 (en) 2008-12-05 2009-01-14 Merten Christoph Assay
WO2010077101A2 (ko) * 2008-12-30 2010-07-08 조선대학교산학협력단 신규한 티아졸리딘디온 유도체 및 그의 용도
BRPI1008749B8 (pt) 2009-02-05 2021-05-25 Immunogen Inc compostos derivados de benzodiazepina, seus conjugados, composição farmacêutica, seu uso e seus processos de preparação
JP2013506709A (ja) 2009-10-06 2013-02-28 イミュノジェン・インコーポレーテッド 有効なコンジュゲートおよび親水性リンカー
US8314250B2 (en) * 2009-11-24 2012-11-20 Hoffmann-La Roche Inc. Sultam derivatives
US8633304B2 (en) * 2009-12-08 2014-01-21 Gifu University Oligonucleotide derivative comprising an aromatic compound
US8962279B2 (en) 2009-12-30 2015-02-24 Intel Corporation Solid-phase chelators and electronic biosensors
EP2536706B1 (en) * 2010-02-11 2017-06-14 Celgene Corporation Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
KR101580713B1 (ko) 2010-02-24 2015-12-29 이뮤노젠 아이엔씨 엽산염 수용체 1 항체와 면역접합체 및 이들의 용도
EP2789622B1 (en) 2010-04-15 2017-03-01 MedImmune Limited Pyrrolobenzodiazepines used to treat proliferative diseases
KR101671360B1 (ko) 2010-04-15 2016-11-01 시애틀 지네틱스, 인크. 표적화된 피롤로벤조디아제핀 접합체
US20110256157A1 (en) 2010-04-15 2011-10-20 Spirogen Limited Pyrrolobenzodiazepines and conjugates thereof
EP3666289A1 (en) 2011-02-15 2020-06-17 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
CN102234253B (zh) * 2011-06-02 2013-07-03 重庆莱美药业股份有限公司 一种制备非布索坦中间体的方法
EP2887965A1 (en) 2012-08-22 2015-07-01 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
KR102298475B1 (ko) * 2013-10-04 2021-09-06 노파르티스 아게 ＲＮＡ 간섭에 사용하기 위한 ＲＮＡｉ 작용제를 위한 3' 말단 캡
CN104628772A (zh) 2013-11-07 2015-05-20 四川恒康发展有限责任公司 一种抗肿瘤前药及其激活剂、组合物和应用
CN103664896B (zh) * 2013-11-25 2016-03-02 济南精合医药科技有限公司 一种抗肿瘤分子靶向药物克里唑替尼的合成工艺方法
WO2016036794A1 (en) * 2014-09-03 2016-03-10 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
EP3189057A1 (en) 2014-09-03 2017-07-12 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
CR20170111A (es) 2014-09-03 2017-05-23 Immunogen Inc Derivados de benzodiazepina citotóxicos
LT3325482T (lt) 2015-07-21 2020-11-25 Immunogen, Inc. Citotoksinių benzodiazepino darinių paruošimo būdai
EP4335851A3 (en) * 2015-11-25 2024-06-05 ImmunoGen, Inc. Pharmaceutical formulations and methods of use thereof

Also Published As

Publication number Publication date
US10899775B2 (en) 2021-01-26
IL283355B (en) 2022-08-01
JP2018522018A (ja) 2018-08-09
EP3653628B1 (en) 2022-09-14
AU2016297608B2 (en) 2021-02-18
AU2023201339A1 (en) 2023-04-06
EP4163284A1 (en) 2023-04-12
IL286788A (en) 2021-10-31
RU2746322C2 (ru) 2021-04-12
AU2021202403B2 (en) 2022-12-08
ES2764548T3 (es) 2020-06-03
IL305989A (en) 2023-11-01
JP7337114B2 (ja) 2023-09-01
US10370389B2 (en) 2019-08-06
CN108026103B (zh) 2021-04-16
JP7334228B2 (ja) 2023-08-28
KR102659706B1 (ko) 2024-04-23
RU2018105609A (ru) 2019-08-26
IL276631A (en) 2020-09-30
RU2018105752A (ru) 2019-08-21
US20170050986A1 (en) 2017-02-23
KR20180038460A (ko) 2018-04-16
EP4286387A3 (en) 2024-02-21
IL294651A (en) 2022-09-01
RU2018105756A (ru) 2019-08-21
IL256860A (en) 2018-03-29
IL305279A (en) 2023-10-01
AU2023202221A1 (en) 2023-05-04
HK1252323A1 (zh) 2019-05-24
US20210171546A1 (en) 2021-06-10
KR20240055894A (ko) 2024-04-29
RS60840B1 (sr) 2020-10-30
CA2992082A1 (en) 2017-01-26
US10392407B2 (en) 2019-08-27
US20190389883A1 (en) 2019-12-26
IL256854A (en) 2018-03-29
CY1122553T1 (el) 2021-01-27
CN108055844A (zh) 2018-05-18
AU2021203148B2 (en) 2023-01-12
EP4286387A2 (en) 2023-12-06
EP3325482B1 (en) 2020-06-24
LT3325482T (lt) 2020-11-25
US11420982B2 (en) 2022-08-23
IL256860B (en) 2020-08-31
PT3325482T (pt) 2020-09-24
JP2022046542A (ja) 2022-03-23
IL276630A (en) 2020-09-30
AU2021202403A1 (en) 2021-05-20
AU2021203148A1 (en) 2021-06-10
PL3325482T3 (pl) 2021-01-11
US20170050985A1 (en) 2017-02-23
EP3325485A1 (en) 2018-05-30
EP3653628A1 (en) 2020-05-20
HRP20201479T1 (hr) 2020-12-11
US20170051011A1 (en) 2017-02-23
JP6787995B2 (ja) 2020-11-18
CA2991305A1 (en) 2017-01-26
CN108290895A (zh) 2018-07-17
CN108026103A (zh) 2018-05-11
RU2018105752A3 (zh) 2019-12-30
WO2017015502A8 (en) 2017-03-02
WO2017015496A1 (en) 2017-01-26
PL3325483T3 (pl) 2020-05-18
EP3778602A1 (en) 2021-02-17
US9890179B2 (en) 2018-02-13
CN113087763A (zh) 2021-07-09
SI3325482T1 (sl) 2020-11-30
DK3325483T3 (da) 2020-01-20
CY1123390T1 (el) 2022-03-24
EP3325483A1 (en) 2018-05-30
CN113004288A (zh) 2021-06-22
AU2016297607A1 (en) 2018-02-08
RU2018105609A3 (zh) 2020-04-30
IL286788B2 (en) 2024-01-01
US20210171547A1 (en) 2021-06-10
AU2016297087B2 (en) 2021-02-18
JP2021100959A (ja) 2021-07-08
PT3325483T (pt) 2020-01-15
WO2017015495A1 (en) 2017-01-26
JP2018526340A (ja) 2018-09-13
WO2017015502A1 (en) 2017-01-26
JP6995178B2 (ja) 2022-02-21
US10081640B2 (en) 2018-09-25
JP6858745B2 (ja) 2021-04-14
EP3325485B1 (en) 2020-04-08
ES2959741T3 (es) 2024-02-28
DK3325482T3 (da) 2020-09-28
US9873708B2 (en) 2018-01-23
RU2018105756A3 (zh) 2019-12-23
US20200017526A1 (en) 2020-01-16
SG10202106529XA (en) 2021-07-29
RS59806B1 (sr) 2020-02-28
CN108290895B (zh) 2021-03-19
ES2820358T3 (es) 2021-04-20
SG10202009354SA (en) 2020-11-27
LT3325483T (lt) 2020-01-27
HK1252321A1 (zh) 2019-05-24
EP3325483B1 (en) 2019-10-02
RU2727151C2 (ru) 2020-07-21
IL256861A (en) 2018-03-29
US20180201626A1 (en) 2018-07-19
CA2991326A1 (en) 2017-01-26
HUE051541T2 (hu) 2021-03-01
KR20180038461A (ko) 2018-04-16
US20230257400A1 (en) 2023-08-17
IL283355A (en) 2021-07-29
SI3325483T1 (sl) 2020-03-31
JP2023162264A (ja) 2023-11-08
US10787463B2 (en) 2020-09-29
KR20180026741A (ko) 2018-03-13
AU2016297087A1 (en) 2018-02-08
IL294651B1 (en) 2023-10-01
US20190112320A1 (en) 2019-04-18
CA3227588A1 (en) 2017-01-26
KR20240055903A (ko) 2024-04-29
AU2016297608A1 (en) 2018-02-08
CA2991305C (en) 2024-03-12
IL286788B1 (en) 2023-09-01
JP2021035958A (ja) 2021-03-04
IL256861B (en) 2020-08-31
EP3778602B1 (en) 2023-07-12
KR102660070B1 (ko) 2024-04-24
JP2018524387A (ja) 2018-08-30
IL294651B2 (en) 2024-02-01
ES2933376T3 (es) 2023-02-06
EP3325482A1 (en) 2018-05-30
US20190010169A1 (en) 2019-01-10
IL276630B (en) 2021-06-30
IL276631B (en) 2021-10-31
JP2023166434A (ja) 2023-11-21

Similar Documents

Publication Publication Date Title
IL291598A (en) History of benzodiazepine cytotoxicity
IL286788A (en) Methods for the preparation of cytotoxic benzodiazepine compounds
IL287405A (en) Methods for preparing cytotoxic benzodiazepine derivatives
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
HUP1400545A2 (hu) Eljárás benzazepin származékok elõállítására
GB201513979D0 (en) Synthesis of benzodiazepine derivatives